Contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

  1. Yadav, S.
  2. Boddicker, N.J.
  3. Na, J.
  4. Polley, E.C.
  5. Hu, C.
  6. Hart, S.N.
  7. Gnanaolivu, R.D.
  8. Larson, N.
  9. Holtegaard, S.
  10. Huang, H.
  11. Dunn, C.A.
  12. Teras, L.R.
  13. Patel, A.V.
  14. Lacey, J.V.
  15. Neuhausen, S.L.
  16. Martinez, E.
  17. Haiman, C.
  18. Chen, F.
  19. Ruddy, K.J.
  20. Olson, J.E.
  21. John, E.M.
  22. Kurian, A.W.
  23. Sandler, D.P.
  24. O'Brien, K.M.
  25. Taylor, J.A.
  26. Weinberg, C.R.
  27. Anton-Culver, H.
  28. Ziogas, A.
  29. Zirpoli, G.
  30. Goldgar, D.E.
  31. Palmer, J.R.
  32. Domchek, S.M.
  33. Weitzel, J.N.
  34. Nathanson, K.L.
  35. Kraft, P.
  36. Couch, F.J.
  37. Montrer des auteurs +
Revue:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Année de publication: 2023

Volumen: 41

Número: 9

Pages: 1703-1713

Type: Article

DOI: 10.1200/JCO.22.01239 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus